Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Why Inclusive Clinical Trials Win On Science, Speed, And Spend
Sponsors who proactively integrate diversity into their trial designs from the earliest phases are finding that it’s not only a matter of fairness but a strategic advantage.
Incorrect Clinical Trial Enrollment Is Preventable. A Tale Of Three Case Studies
See how three clinical trials used centralized eligibility review to accelerate enrollment, eliminate enrollment-based protocol deviations, and keep studies on track, even at a global scale.
Breaking The Trial Bottleneck: Smarter, Faster Paths To Patients
AI is speeding clinical trials — but silos and complexity persist. Discover how connected systems and automation can enable faster, more adaptive development.
SCOPE 2026 In The Rear-View Mirror
Another SCOPE Summit is in the record books, and it was jam-packed with informative sessions. Themes included patient-centricity, AI (no surprise here), patient recruitment, and much more.

Decentralized Trials Still Need Connected Support
7/23/2026

Decentralized and hybrid trials reduce travel burdens but add coordination challenges. Strong support improves communication, engagement, and smooth trial execution from enrollment to completion.
RTSM Automating Adaptive Enrollment In Basket Trials
6/26/2026

Adaptive basket trials need real-time data to close underperforming cohorts fast. See how automation closes that gap and protects patients.
Mastering Scope 3 Emissions In Clinical Trials
10/23/2024

Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
Where PRO Strategy Goes Wrong
5/27/2026

PRO and COA strategy is now central to trial success. Organizations that capture meaningful patient experience data will gain stronger evidence and a regulatory advantage.
CRF Validation Best Practices: Building Reliable Clinical Trial Databases
6/29/2026

CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.

A Hands-On Approach To End-To-End Rater Services

If rater quality is a risk your study can't afford to take, now is the time to evaluate whether your current approach has the structure to support it.
Selecting The Right Pain Model For Early Phase Analgesic Trials

Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
Rethinking Lab Logistics: Delivering The Complex Without Compromise

Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.
Your Top Partner For Ophthalmic Drug Development

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
Run Trials With Less Friction. Execute With More Confidence.

Modern RTSM capabilities help streamline study execution, support compliance, and provide greater visibility across complex global clinical trials.